跳至主要内容
临床试验/JPRN-UMIN000014243
JPRN-UMIN000014243已完成3 期

Randomized controlled study of GnRH antagonist monotherapy and CAB with GnRH agonist plus bicalutamide for patients with metastatic prostate cancer. - Randomized controlled study of GnRH antagonist monotherapy and CAB with GnRH agonist plus bicalutamide for patients with metastatic prostate cancer.(KYUCOG-1401)

Clinical Research Support Center Kyushu0 个研究点目标入组 200 人开始时间: 2014年6月12日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1. Patients with history of treatment or under treatment on prostate cancer. 2. Patients with active double cancer. Patients with history of malignant tumor within the past 5 years are regarded as having active double cancer. The basal cell carcinoma that radical treatment was taken or superficial squamous cell carcinoma are not included in active double cancer.) 3. Patients with less than 20 years of age on the enrollment day. 4. Any other patients who are regarded as unsuitable for this study by the investigators.

研究者

发起方
Clinical Research Support Center Kyushu

相似试验